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Objective. Prevalence of hypertension is on the rise and can be attributed to aging populations and changing behavioral or lifestyle
risk factors. -e objectives of this study were to determine the prevalence, awareness, treatment, control, and risk factors of
hypertension in the middle part of Ghana. Methods. A total of 2,555 participants aged ≥18 years (mean age of 43 years; 60.5%
female) were enrolled using a two-stage sampling method.-eWorld Health Organization STEPwise approach to chronic disease
risk factor Surveillance-Instrument v2.1 was used for data collection. Blood pressure and anthropometric measurements were
assessed. Blood glucose and lipids were also measured using blood samples collected after an overnight fast. Results. Prevalence of
hypertension was 28.1% (95% CI: 26.3%–29.8%). Less than half, i.e., 45.9% (95% CI: 42.2%–49.6%), of the respondents were aware
of their hypertensive status. Of those aware and had sought medical treatment, 41.3% (95% CI: 36.1–46.8) had their hypertension
controlled. Risk factors associated with being hypertensive were current (p � 0.053) and past tobacco usage (p< 0.001), pre-
diabetes (p � 0.042), high body mass index (p< 0.001), hyperglycaemia (p � 0.083), and hypercholesterolaemia (p � 0.010).
Doing vigorous work and being active in sports were less associated with being hypertensive (p< 0.001). Conclusion. Our study
showed that close to one-quarter of adults who were involved in the survey in the middle belt of Ghana were hypertensive with less
than half being aware of their hypertensive status; nearly half of those on treatment had controlled hypertension. Healthcare
systems need adequate resources that enable them to screen, educate, and refer identiﬁed hypertensive patients for appropriate
management to prevent or minimize the development of hypertension-related complications.
1. Introduction
Hypertension is a major public health challenge, aﬀecting
populations from both economically developed and de-
veloping countries globally [1, 2]. -e disease remains a
major risk factor for development of cardiovascular disease
(CVD), which was responsible for 17.7 million deaths
worldwide in 2015 (i.e., 45% of deaths due to non-
communicable diseases) [3]. -e highest prevalence of hy-
pertension in the world occurs in sub-Saharan Africa [4].
Many patients with hypertension are asymptomatic and
predisposed to fatal cardiovascular events such as strokes
and myocardial infarctions; hence, the the disease is de-
scribed as a “silent killer” [5]. Depending on the aetiology,
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hypertension could be classiﬁed as primary (aﬀecting 90–
95% of patients) or secondary (resulting from an underlying
condition) [5].
Although the exact cause of primary hypertension is
unknown, there are several nonmodiﬁable and modiﬁable
risk factors that have been linked to the condition. Non-
modiﬁable risk factors for hypertension include age, sex,
race, family history, and genetic composition, whereas
modiﬁable risk factors include obesity, excessive salt intake,
inactivity or lack of exercise, high fat diet, tobacco use, and
alcohol consumption [5–7]. According to the 2014 Ghana
Demographic and Health Survey (GDHS), the overall
prevalence of hypertension among persons aged 15–49 years
was 13.0%, with nearly half of them being aware of their
hypertensive status [8]. A systematic review and meta-
analysis by Bosu also reported a prevalence of adult hy-
pertension between 19% and 48% [9].
Although the prevalence of hypertension was de-
termined as part of the GDHS in 2014, this survey did not
include biochemical measurements as outlined in the WHO
STEPwise approach to chronic disease risk factor Surveil-
lance-Instrument v2 due in part to cost considerations. A
well-structured epidemiological survey to determine the
prevalence, management, and risk factors including bio-
chemical risk are vital to compliment that of the GDHS for
the implementation and evaluation of the impact of in-
terventions to control hypertension. A multiphased Kin-
tampo Noncommunicable diseases (NCD) Initiative (KNI)
programme incorporating the WHO STEPwise approach
was established at the Kintampo Health Research Centre
(KHRC) in 2015 to build capacity for NCD epidemiologic
studies that would lead to interventional studies. -is
community-based epidemiological screening survey that
establishes the burden of hypertension in the middle belt of
Ghana initiated the programme.
2. Methods
2.1. Study Design and Setting. A community-based cross-
sectional study was conducted in two contiguous districts
(Kintampo North Municipality and Kintampo South Dis-
trict) in the middle part of Ghana between October 2015 and
December 2016. -e study area, which lies in the geo-
graphical center of Ghana, has a total resident population of
about 129,000 of which about two-thirds is rural [10]. -ere
were two government hospitals, two private hospitals, four
health centers, one private clinic, 25 community-based
health planning and services (CHPS) areas, and two ma-
ternity homes that serve the population. -e KHRC
maintains a Health and Demographic Surveillance System
(HDSS), which collects core information such as births,
deaths, and migrations (in and out). Houses within the study
area have been numbered and digitized, facilitating tracing
of potential study participants in their homes [10].
Five days of training was organized for the clinical,
laboratory, ﬁeld, and data teams involved in the study
covering implementation of the study protocol, speciﬁ-
cally interviewing techniques, informed consenting pro-
cess, anthropometric measurements, completion of the
study questionnaire, and referral systems. -eoretical
presentations and role play were employed during training
sessions. Study tools were piloted within the community
prior to commencement of the study.
2.2. Ethical Considerations. Ethical approval was obtained
from the Kintampo Health Research Centre Institutional
Ethics Committee (KHRCIEC/2014–25). Individual written
informed consent was obtained from each participant before
study procedures were carried out.
2.3. Sample Size. Based on an overall hypertension preva-
lence of 13.0% in the Ghanaian population status [8], a
prevalence of 9.5% was used for the study area. Assuming a
0.05 type I error rate and a 0.011margin of error, a minimum
sample of 2,482 was estimated. Assuming a 10% non-
response rate, a sample size of 2,730 was used. -e sample
size calculation was based on the following formula:
n � Z
2
1− (α/2)
P(1 − P)
d2
, (1)
where n� sample size, Z1− (α/2) � type I error rate
(0.05�1.96), P � assumed hypertension prevalence (13.0%),
and d�margin of error (0.011).
2.4. Selection of Study Communities and Participants. -e
sampling frame was the database of the Kintmapo Health
and Demographic Surveillance System (KHDSS). A two-
stage sampling procedure was used in selecting the study
population, ensuring that they were representative of the
KHDSS population. In the ﬁrst stage, 34 of the 164 com-
munities in the KHDSS area were randomly selected using
computer-generated random numbers and ensuring that the
entire target population was covered. -is was followed by
visits to the leaders of the selected communities to explain
the study to them and to seek their permission for partic-
ipation of members’ of their communities. -e second stage
involved stratiﬁcation by gender and ascending age, of all
individuals of 18 years and older in the selected commu-
nities. Potential study participants were then selected at
random from the identiﬁed communities using a systematic
sampling technique, which involved the selection of an
“indexed” individual from the database of each selected
community followed by the selection of every tenth indi-
vidual. Listings of potential study participants were used by
our study ﬁeld workers who met the participants at home in
the communities to explain the study to them and also invite
them to a central location within the community for them to
go through study procedures. Inclusion criteria were adult
male and female subjects aged ≥18 years who have been
resident in the study area for at least 6 months and were
willing to be part of the study.
2.5. Study Procedures. Following informed consent, ques-
tionnaires were administered to obtain demographic data,
information on tobacco use, alcohol consumption, diet,
physical activity, history of raised blood pressure, and
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diabetes, using the World Health Organization (WHO)
STEPwise approach to chronic disease risk factor Surveil-
lance-Instrument v2.1 [11]. All administered questionnaires
were checked for completeness in the ﬁeld and before data
entry.
2.6. Blood Pressure Measurement. -ree sedentary blood
pressure (BP) measurements were taken at 3-minute in-
tervals by a physician assistant using an Omron digital BP
monitor (Omron Healthcare Co. Kyoto, Japan) with a cuﬀ of
appropriate width after the participant had sat for at least 15
minutes and relaxed.
2.7. BodyWeight andHeightMeasurement. Two trained ﬁeld
staﬀ measured and veriﬁed the body weight and height with
the participant standing motionless in an erect position
against the vertical surface of a standard height meter at-
tached to a calibrated weighing scale. Participants had on
minimum clothing and no footwear while their body weight
and height were being measured.
2.8. Laboratory Measurements. Overnight fasting blood
samples (3ml) were obtained by sterile venipuncture from
each participant and dispensed into 1ml ﬂuoride-EDTA and
2ml lithium heparin tubes for the estimation of glucose and
lipids, respectively. Plasma was separated after centrifuga-
tion of blood at 1000g for 10min. Glucose, cholesterol, and
triglyceride levels were determined the same day using a
Flexor E automated Clinical Chemistry analyzer (Vital
Scientiﬁc, -e Netherlands) according to approved standard
operating procedures. Samples that were to be analyzed later
were kept frozen at − 20°C or below and thawed prior to
analysis. Freeze-thaw cycles were avoided.
2.9. Outcome Deﬁnitions. We used deﬁnitions by the Sev-
enth Report of the Joint National Committee on the Pre-
vention, Detection, Evaluation and Treatment of High Blood
Pressure [12]. Hypertension was deﬁned as a mean systolic
blood pressure (SBP) of ≥140mmHg and/or a mean DBP of≥90mmHg or a respondent self-report of clinician diagnosis
of hypertension or self-report of medication to lower blood
pressure. Prehypertension was also deﬁned as SBP of
120–139mmHg and DBP of 80–89mmHg; stage 1 hyper-
tension as SBP of 140–159mmHg and/or DBP 90–
99mmHg; and stage 2 hypertension as SBP of ≥160mmHg
and/or DBP ≥100mmHg. Awareness was deﬁned as self-
report of a diagnosis of hypertension by a health worker.
Control was deﬁned as self-reported taking of medication to
lower blood pressure with SBP of <140mmHg and DBP of<90mmHg. Aware yet not on medication was deﬁned as
self-reported diagnosis by a health worker yet not taking
medication to lower blood pressure. Diabetes mellitus was
deﬁned as fasting blood glucose level of ≥7.0mmol/L
or reported use of blood glucose lowering medication,
whereas hypercholesterolemia and hypertriglyceridemia
were deﬁned as total cholesterol and triglyceride levels of≥5.0mmol/L and ≥2.2mmol/L, respectively.
Participants found to be hypertensive or having any
other medical condition were counseled by a study clinician
and referred to a health facility for treatment. All partici-
pants with a measured SBP of ≥140mmHg and/or DBP of≥90mmHg were referred to the Municipal/District hospital
or to their clinicians for appropriate management.
2.10. Data Management, Statistical Methods, and Analysis.
Data were double entered, veriﬁed using (C Sharp) Visual
Studio 2013 as front end and SQL server as back end prior to
analysis. Means of second and third blood pressure mea-
surements were used for the analysis. Measurement of
household socioeconomic status was based on respondent’s
household assets. -e assets were scored, and eigenvalues
were computed using principal component analysis. By this
method, the weighted assets were grouped into various
components. -e ﬁrst component was used to generate the
wealth quintiles. Variables were summarized using de-
scriptive statistics. Chi-square test was used to ﬁnd the
relationship between being hypertensive and known risk
factors. -e analysis was done in Stata version 14.0 (Sta-
taCorp, USA).
3. Results
A total of 2,555 participants (60.5% female) from the HDSS
area were enrolled into the survey following consenting
(Table 1). Participants’ enrolment was proportional to the
population structure. For the risk set, those aged 18–39 years
were in the majority (45.3%), followed by those aged 40–
59 years (35.7%). Approximately 41% of participants had no
education, and 15.6% had a postsecondary educational
status (e.g., training colleges and polytechnics) as their
highest educational level. Majority (29%) of the participants
were from households with least poor socioeconomic status.
3.1. Prevalence of Hypertension. -e overall prevalence of
hypertension in the surveyed population was 28.1% (95% CI:
26.3–29.8%; 717/2555), and this increased with age. Age-
speciﬁc prevalence of hypertension for participants aged
18–39 years, 40–59 years, and ≥60 years were 12.9% (95% CI:
11.1–15.0%), 33.8% (95% CI: 30.8–37.0%), and 53.3% (95%
CI: 48.8–57.7%), respectively.
Prevalence of the diﬀerent types of raised blood pressure,
i.e., prehypertension, systolic hypertension, diastolic hy-
pertension, stage 1 hypertension, and stage 2 hypertension
were 42.5% (95% CI: 40.6%–44.5%), 8.5% (95% CI: 7.5%–
9.7%), 3.2% (95% CI: 2.6%–3.9%), 15.8% (95% CI: 14.4%–
17.2%), and 8.9% (95% CI: 7.9%–10.1%), respectively
(Table 2).
Diastolic hypertension was the least common type of
hypertension in the population but was most prevalent
within 40–59 years. With the exception of diastolic hyper-
tension, participants aged ≥60 years generally had the most
prevalent proportion for all the various types of hyperten-
sion. Close to a ﬁfth (19%) of those aged ≥60 years had stage
2 hypertension (Table 2).
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Prevalence of the diﬀerent stages of hypertension in male
and female subjects is presented in Table 3. Male subjects
had a signiﬁcantly higher prevalence of prehypertension
(p< 0.001) and stage-1 hypertension (p � 0.002) compared
with female subjects.
3.2. Awareness, Treatment, and Control of Hypertension.
Out of the 717 respondents who were classiﬁed as hyper-
tensive, 45.9% (95% CI: 42.2–49.6; 329/717) had in the past
been diagnosed and informed by a health practitioner and
were aware of their status (Table 4). Level of awareness
increased signiﬁcantly with age group (p< 0.001), being
highest in the ≥60 years group and lowest in the 18–39 years
group. Out of the 329 hypertensive respondents who were
aware of their status, 54.1%, 3.6%, and 2.4% of them had
sought for medical, herbal, and both medical and herbal
treatments, respectively. Among those who sought medical
treatment, 41% had their raised blood pressure controlled,
while 59% had uncontrolled blood pressure. A higher
proportion of participants aged ≥60 years had sought
treatment (Table 4).
3.3. Risk Factors for Hypertension. Current usage of tobacco
was highest (3.2%) among the age group of 40–59 years’
compared with the other age categories (Supplementary 1).
Hypertensive respondents who have ever or within the past
12 months or within the past 30 days consumed alcohol were
Table 1: Distribution of respondents’ basic demographic characteristics.
Demographic characteristics
Respondent’s age group Overall total (2,555)
18–39 years 40–59 years 60 and above years
n (%)N� 1,158 N� 913 N� 484
n (%) n (%) n (%)
Gender
Male 441 (38.1) 353 (38.7) 215 (44.4) 1,009 (39.5)
Female 717 (61.9) 560 (61.3) 269 (55.6) 1,546 (60.5)
Residence type
Urban 467 (40.3) 293 (32.1) 151 (31.2) 911 (35.7)
Rural 691 (59.7) 620 (67.9) 333 (68.8) 1,644 (64.3)
Education status
None 246 (21.2) 455 (49.8) 342 (70.7) 1,043 (40.8)
Primary 194 (16.7) 131 (14.3) 42 (8.7) 367 (14.4)
Secondary 436 (37.6) 238 (26.1) 73 (15.1) 747 (29.2)
Postsecondary 282 (24.3) 89 (9.7) 27 (5.6) 398 (15.6)
Registered with NHIS1
Yes 484 (41.8) 464 (50.8) 290 (59.9) 1,238 (48.4)
No 674 (58.2) 449 (49.2) 194 (40.1) 1,317 (51.6)
HH SES2
Least poor 330 (28.5) 272 (29.8) 144 (29.7) 746 (29.2)
Less poor 287 (24.8) 215 (23.5) 122 (25.2) 624 (24.4)
Poor 229 (19.8) 147 (16.1) 86 (17.8) 462 (18.1)
More poor 155 (13.4) 154 (16.9) 64 (13.2) 373 (14.6)
Most poor 140 (12.1) 108 (11.8) 65 (13.4) 313 (12.2)
Missing 17 (1.5) 17 (1.9) 3 (0.6) 37 (1.4)
1NHIS: National Health Insurance Scheme; 2HH SES: household socioeconomic status.
Table 2: Various types of hypertension prevalence by age group within the surveyed population.
Raised blood pressure type
Respondent’s age group
Total (2,555)18–39 years
(N� 1,158)
40–59 years
(N� 913)
60 and above years
(N� 484)
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
Prehypertension 38.6 (35.8–41.1) 44.5 (41.3–47.7) 48.3 (43.9–52.8) 42.5 (40.6–44.5)
Systolic hypertension 3.4 (2.5–4.6) 8.2 (6.6–10.2) 21.5 (18.0–25.4) 8.5 (7.5–9.7)
Diastolic hypertension 3.0 (2.2–4.2) 3.9 (2.8–5.4) 2.3 (1.3–4.1) 3.2 (2.6–4.0)
Hypertension (stage 1) 8.3 (6.8–10.0) 18.8 (16.4–21.5) 27.9 (24.1–32.1) 15.8 (14.4–17.2)
Hypertension (stage 2) 2.3 (1.6–3.4) 12.0 (10.1–14.3) 19.0 (15.7–22.7) 9.0 (7.9–10.1)
Table 3: Prevalence of the diﬀerent stages of hypertension among
male and female subjects in the study area.
Stage of hypertension Male Female Diﬀerence P value
Prehypertension 49.3 38.1 11.3 <0.001
Systolic hypertension 9.3 8.0 1.3 0.252
Diastolic hypertension 3.3 3.2 0.1 0.887
Stage 1 hypertension 18.5 14.0 4.6 0.002
Stage 2 hypertension 8.9 9.0 − 0.1 0.951
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approximately 38%, 22%, and 19%, respectively. Con-
sumption of alcohol within the past 30 days was approxi-
mately 18% for each of the age groups (Supplementary 1).
Approximately 85% and 21% of hypertensive re-
spondents were involved in active work and sports, re-
spectively. Approximately 10% of these respondents also
had diabetes, with the prevalence being highest (11.0%)
for respondents within the 40–59 years group. About half
of the hypertensive respondents had a normal BMI.
Majority of hypertensive respondents had hypercholes-
terolemia, with proportions being highest (59.9%) for
respondents of ≥60 years. Proteinuria (≥0.3 g/L) was
present in 3.5% (25/714) of hypertensive patients (Sup-
plementary 1).
Risk factors found to be associated with one being hy-
pertensive were current tobacco usage (p � 0.053), past
tobacco usage (p< 0.001), prediabetes (p � 0.042), high BMI
(p< 0.001), hyperglycaemia (p � 0.038), and hyper-
cholesterolaemia (0.010), whereas being active in sports and
doing vigorous work were both less associated with hy-
pertension (p< 0.001) (Supplementary 1). -e risk factors
were the same for both male and female subjects across the
diﬀerent age groups.
4. Discussion
-is community-based epidemiological screening study
establishes that the prevalence of hypertension is higher than
expected in predominantly rural communities in Ghana.-e
overall prevalence was consistent with what was reported by
Bosu as the prevalence of hypertension among adults in
Ghana [9], Mohammed et al. among Kenyans [7], and Arrey
et al. among Cameroonians [13]. Our value, however, was
lower compared with those from other cross-sectional
studies in Cameroon [14, 15], Ghana [16], Kenya [17], South
Africa [16, 18], and Tanzania [19], where the overall prev-
alence of hypertension was more than 40% of the study
populations. -e high prevalence of hypertension in this
rural setting could be attributed to the changing lifestyles of
rural residents to increasingly reﬂect those of urban dwellers,
including alcohol abuse, smoking, lack of physical exercise,
and high intake of salt and fatty foods. -e increased
prevalence of hypertension with age reported in this study
has been well documented in other studies [1, 20–22]. Ar-
terial stiﬀening as a result of aging has been described as a
contributory factor for the higher predisposition to hyper-
tension among the elderly [23–25].
Our demonstration that more than half of participants
with hypertension were not aware of their condition is in
agreement with ﬁndings in several other studies [4, 7, 26].
Low access to healthcare services and poor health seeking
behavior could be contributing factors to the low levels of
awareness. -e high proportion of persons identiﬁed with
hypertension and not on treatment reported in our study is
similar to the 59.5% reported by Sanuade et al. [8] in a
national survey in Ghana but lower compared with the
84.4% reported by Mohammed et al. [7] from a national
survey in Kenya.
Our ﬁndings on the proportion of controlled hyper-
tension in the diﬀerent age groups were similar to the United
States National Health and Nutrition Examination Surveys
(NHANES) 1999–2014, which also showed lowest level of
control among persons 18–39 years [21]. -e nearly hy-
pertension control rate reported in our study was similar to
the 51% reported by Mohamed et al. in Kenya [7] but higher
than the nearly one-third prevalence of controlled hyper-
tension in the study by Khader et al. in Jordan [27] and the
23.8% reported by Sanuade et al. in a national survey in
Ghana [8]. Although not optimal, the higher level of hy-
pertension control compared with others could be due to
higher levels of compliance to treatment regimens by per-
sons with hypertension in our study area.
-e high proportion of persons who knew they were
hypertensive but were not on any treatment could be due to
poor adherence and subsequent default to treatment. -is
has been attributed to factors such as inadequate counseling,
misconceptions that hypertension is curable, and high cost
of drugs [28–30]. More education on hypertension pre-
vention and treatment through task shifting at the com-
munity level, taking hypertension (and other NCDs)
healthcare to the doorsteps of community members, ﬁ-
nancing, and availability of hypertension medication
through the National Health Insurance Scheme (NHIS) will
contribute signiﬁcantly to improvements in treatment rates
among hypertensive individuals who are aware of their
status [31]. Factors associated with hypertension in our
study area were similar to ﬁndings from other studies
[32, 33]. Health education and other interventions should
target these risk factors to improve hypertension prevention
and management.
5. Limitations
A key limitation is that some responses were subjective and
self-reported. -ese responses could have been aﬀected by
recall bias. However, the use of well-trained interviewing
staﬀ and Show Cards to explain the questions ensured that,
as much as possible, accurate responses were obtained.
Table 4: Awareness, treatment, and control of hypertension among the study population.
HPT
(N) Aware
Aware,
% (95% CI)
Treated and controlled,
% (95% CI)
Aware, not treated
% (95% CI)
Age group (years)
18–39 150 54 36.0 (28.7–44.0) 18.5 (10.2–31.3) 81.4 (68.7–89.8)
40–59 309 148 47.9 (42.4–53.5) 37.2 (29.7–45.3) 62.8 (54.7–70.3)≥60 258 127 49.2 (43.1–55.3) 55.9 (47.1–64.3) 44.1 (35.6–52.9)
All 717 329 45.9 (42.2–49.6) 41.3 (36.1–46.8) 58.7 (53.2–63.9)
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6. Conclusions
Our study showed that close to one-quarter of adults in the
middle belt of Ghana had hypertension with less than half of
them being aware of their hypertensive status, and nearly
half of those on treatment having controlled hypertension.
Healthcare systems need adequate resources that will enable
them to screen, educate, and refer identiﬁed hypertensive
individuals for appropriate management to prevent or
minimize the development of complications.
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